We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Combination of Ibrutinib and Rituximab Prolongs Progression-Free Survival in Waldenstrom Macroglobulinemia.
- Authors
Isaac, Daniel
- Subjects
ANTINEOPLASTIC agents; CONFIDENCE intervals; GENETIC mutation; LYMPHOPROLIFERATIVE disorders; HEALTH outcome assessment; PLACEBOS; STATISTICAL sampling; SURVIVAL analysis (Biometry); RANDOMIZED controlled trials; TREATMENT effectiveness; DISEASE progression; DESCRIPTIVE statistics; ODDS ratio; GENOTYPES; PHARMACODYNAMICS; PROGNOSIS
- Publication
Journal of Clinical Outcomes Management, 2018, Vol 25, Issue 9, p400
- ISSN
1079-6533
- Publication type
Article